Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

[18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy Patients

NCT06738862 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT06738862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06738862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
[18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy Patients
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Completed
Start date
December 14, 2024
Completion date
December 25, 2025
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple system atrophy, parkinson's disease (pd), pet, rapid eye movement sleep behavior disorder, α-synucleinopathy